Advertisement

Molecular Biology Reports

, Volume 40, Issue 1, pp 535–543 | Cite as

Transforming growth factor-β genetic polymorphisms on development of liver cirrhosis in a meta-analysis

  • Xiao-Dan Wu
  • Kai Zeng
  • Can-Sheng Gong
  • Jinhua Chen
  • Yan-Qing Chen
Article

Abstract

Transforming growth factor-β (TGF-β) protein has been supposed to be a risk factor for liver cirrhosis; however, the associations between its genes (TGF-β −509C>T and +869T>C) and liver cirrhosis remained unclear. This study was to quantitatively analyze the correlations by using a meta-analysis. Pubmed, Embase, Wanfang databases were retrieved up to November 1st, 2011. Odds ratio (OR) and 95 % confidence interval (95 %CI) were used to demonstrate the strength of association, and P < 0.05 of Z test indicated statistical significance. Combined analyses were performed by using fixed or random-effect model, depending on between-study heterogeneity. Seven studies were for TGF-β −509C>T polymorphism, and eight studies were for +869T>C polymorphism. Combined results indicated that neither TGF-β −509C>T nor +869T>C polymorphisms were associated with risk of liver cirrhosis [OR (95 % CI): 0.79 (0.60–1.04) for CT vs. TT of −509C>T and 0.87 (0.68–1.12) for CT vs. CC of +869T>C], with no between-study heterogeneity. In addition, subgroups analyses still inferred that two polymorphisms were not associated with risk of liver cirrhosis for HBV-infected patients, Asians and for Population-based studies. This meta-analysis indicated that neither TGF-β −509C>T nor +869T>C polymorphisms were associated with risk of liver cirrhosis, regardless of HBV infection or not.

Keywords

Transforming growth factor Polymorphism Risk Liver cirrhosis Meta-analysis 

Notes

Acknowledgments

Grants covering the research: We gratefully acknowledge the financial support of the Project supported by the Natural Science Foundation of Fujian Province, China (Grant No. 2012Y0012 ) and the Project supported by the Medical Innovation Foundation of Fujin Province, China (Grant No. 2012-CX-2).

Conflict of interest

None for all authors.

References

  1. 1.
    Thomas MB, Zhu AX (2005) Hepatocellular carcinoma: the need for progress. J Clin Oncol 23:2892–2899PubMedCrossRefGoogle Scholar
  2. 2.
    Marrero JA, Kudo M, Bronowicki JP (2010) The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist 15(Suppl 4):23–33PubMedCrossRefGoogle Scholar
  3. 3.
    Andersen ES, Ruhwald M, Moessner B, Christensen PB, Andersen O, Eugen-Olsen J et al (2011) Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1. Eur J Clin Microbiol Infect Dis 30:761–766PubMedCrossRefGoogle Scholar
  4. 4.
    Purohit V, Brenner DA (2006) Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman symposium. Hepatology 43:872–878PubMedCrossRefGoogle Scholar
  5. 5.
    Lang Q, Liu Q, Xu N, Qian KL, Qi JH, Sun YC et al (2011) The antifibrotic effects of TGF-beta1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun 409:448–453PubMedCrossRefGoogle Scholar
  6. 6.
    Lin N, Chen S, Pan W, Xu L, Hu K, Xu R (2011) NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats. Am J Physiol Cell Physiol 301:C469–C477PubMedCrossRefGoogle Scholar
  7. 7.
    Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC et al (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93–97PubMedCrossRefGoogle Scholar
  8. 8.
    Wang H, Zhao YP, Gao CF, Ji Q, Gressner AM, Yang ZX et al (2008) Transforming growth factor beta 1 gene variants increase transcription and are associated with liver cirrhosis in Chinese. Cytokine 43:20–25PubMedCrossRefGoogle Scholar
  9. 9.
    Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D et al (2008) TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine 44:256–261PubMedCrossRefGoogle Scholar
  10. 10.
    Jiang Z-L, Zhang W, Zhang H, Liu Y-BL, Su S-B (2009) Relationship between TNF-α, TGF-β1 and IL-10 genetic polymorphisms and posthepatitis B cirrhosis. Hua Ren Xiao Hua Za Zhi 17:3263–3268Google Scholar
  11. 11.
    Shi W, Guo J, Chen Q, Wang Y, Xun Y, Shi J et al (2011) Association between TGF—n gene polymorphism and hepatocirrhosis in Chinese patients with chronic HBV infection. Yi Xue Yan Jiu Za Zhi 40:93–96Google Scholar
  12. 12.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  13. 13.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  14. 14.
    Ma Y, Tang RK, Yang X, Peng GG, Liu Y, Wang XM et al (2011) Lack of an association between interleukin-6 gene promoter polymorphisms (−174G/C, −572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol 72:641–651PubMedCrossRefGoogle Scholar
  15. 15.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedCrossRefGoogle Scholar
  16. 16.
    Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV (2000) Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 12:1329–1333PubMedCrossRefGoogle Scholar
  17. 17.
    Yang ZX, Wang H, Gao CF, Xu LL, Zhao WP (2005) Effect of polymorphism of transforming growth factor b1 gene on HBV-induced liver cirrhosis. Zhong Hua Yi Xue Za Zhi 85:1021–1026Google Scholar
  18. 18.
    Kikuchi K, Tanaka A, Matsushita M, Kitazawa E, Hosoya N, Kawashima Y et al (2007) Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients. Ann N Y Acad Sci 1110:15–22PubMedCrossRefGoogle Scholar
  19. 19.
    Li H, Wu H-L, Lv H, Wei H-S, Wang H-B, Wang P-L (2007) The association of TGFb1and AT1R gene polymorphisms with hereditary susceptibility and clinical phenotype of HBV-induced liver cirrhosis. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 24:298–301Google Scholar
  20. 20.
    Yu SK, Kwon OS, Jung HS, Bae KS, Kwon KA, Kim YK et al (2010) Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers. J Korean Med Sci 25:564–569PubMedCrossRefGoogle Scholar
  21. 21.
    Lee JJ, Park SK, Kwon OS, Won IS, Kim DK, Jung YK et al (2011) Genetic polymorphism at codon 10 of the transforming growth factor-beta1 gene in patients with alcoholic liver cirrhosis. Korean J Hepatol 17:37–43PubMedCrossRefGoogle Scholar
  22. 22.
    Gieling RG, Wallace K, Han YP (2009) Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 296:G1324–G1331PubMedCrossRefGoogle Scholar
  23. 23.
    Marcos M, Gomez-Munuera M, Pastor I, Gonzalez-Sarmiento R, Laso FJ (2009) Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol 170:948–956PubMedCrossRefGoogle Scholar
  24. 24.
    Huang Q, Shao F, Wang C, Qiu LJ, Hu YG, Yu JH (2011) Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis. Arch Med Res 42:235–238PubMedCrossRefGoogle Scholar
  25. 25.
    Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291–1306PubMedCrossRefGoogle Scholar
  26. 26.
    Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA et al (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324–1332PubMedCrossRefGoogle Scholar
  27. 27.
    Al-Mulla F, Leibovich SJ, Francis IM, Bitar MS (2011) Impaired TGF-beta signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol BioSyst 7:3006–3020PubMedCrossRefGoogle Scholar
  28. 28.
    Dooley S, Ten Dijke P (2011) TGF-beta in progression of liver disease. Cell Tissue Res 347(1):245–256PubMedCrossRefGoogle Scholar
  29. 29.
    Xiang TX, Cheng N, Li XN, Wu XP (2012) Association between transforming growth factor-beta1 polymorphisms and hepatocellular cancer risk: a meta-analysis. Hepatol Res 42(6):583–590PubMedCrossRefGoogle Scholar
  30. 30.
    Chuang HY, Ng LT, Lin LT, Chang JS, Chen JY, Lin TC et al (2011) Hydrolysable tannins of tropical almond show antifibrotic effects in TGF-beta1-induced hepatic stellate cells. J Sci Food Agric 91:2777–2784PubMedCrossRefGoogle Scholar
  31. 31.
    Tache D, Bogdan F, Pisoschi C, Banita M, Stanciulescu C, Fusaru AM et al (2011) Evidence for the involvement of TGF-beta1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection. Rom J Morphol Embryol 52:409–412PubMedGoogle Scholar
  32. 32.
    Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN et al (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356–1361PubMedCrossRefGoogle Scholar
  33. 33.
    Wang, H., Liu, C. (2011) Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos Int. doi: 10.1007/s00198-011-1885-6

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Xiao-Dan Wu
    • 1
  • Kai Zeng
    • 2
  • Can-Sheng Gong
    • 1
  • Jinhua Chen
    • 3
  • Yan-Qing Chen
    • 1
  1. 1.Department of AnesthesiologyFujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical UniversityFuzhouChina
  2. 2.Department of AnesthesiologyThe First Affiliated Hospital, Fujian Medical UniversityFuzhouChina
  3. 3.Department of StatisticsFuzhou General Hospital of Nanjing Military RegionFuzhouChina

Personalised recommendations